I agree that this site is using cookies. You can find further informations here.
X
Villegas, Augusto
206  results:
Search for persons X
?
1

Symptomatic Pneumonitis With Durvalumab After Concurrent Ch..:

Vansteenkiste, Johan F. ; Naidoo, Jarushka ; Faivre-Finn, Corinne...
JTO Clinical and Research Reports.  5 (2024)  3 - p. 100638 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Response of FGFR-2 Positive Adenoid Cystic Carcinoma to Fut..:

Rodriguez, Yoan E ; Shahid, Maham ; Badillo, Natalia..
Cureus.  , 2024
Link: https://doi.org/10.7759/..
 
?
3

Urachal Adenocarcinoma: A Rare Primary Cancer Managed With ..:

Patel, Jay ; Villegas, Augusto
Cureus.  , 2023
Link: https://doi.org/10.7759/..
 
?
4

COVID-19: A Rare Cause of Hemolytic Uremic Syndrome:

Boldig, Kimberly ; Batra, Rishu ; Villegas, Augusto
Cureus.  , 2022
Link: https://doi.org/10.7759/..
 
?
5

Impact of prior chemoradiotherapy-related variables on outc..:

Faivre-Finn, Corinne ; Spigel, David R. ; Senan, Suresh...
Lung Cancer.  151 (2021)  - p. 30-38 , 2021
Link: https://doi.org/10.1016/..
 
?
6

Durvalumab After Concurrent Chemoradiotherapy in Elderly Pa..:

Socinski, Mark A. ; Özgüroğlu, Mustafa ; Villegas, Augusto...
Clinical Lung Cancer.  22 (2021)  6 - p. 549-561 , 2021
Link: https://doi.org/10.1016/..
 
?
7

Three-Year Overall Survival with Durvalumab after Chemoradi..:

Gray, Jhanelle E. ; Villegas, Augusto ; Daniel, Davey...
Journal of Thoracic Oncology.  15 (2020)  2 - p. 288-293 , 2020
Link: https://doi.org/10.1016/..
 
?
8

Hypokalemic Paralysis Secondary to Immune Checkpoint Inhibi..:

Balakrishna, Pragathi ; Villegas, Augusto
Case Reports in Oncological Medicine.  2017 (2017)  - p. 1-4 , 2017
Link: https://doi.org/10.1155/..
 
?
9

Durvalumab After Concurrent Chemoradiotherapy in Elderly Pa..:

Socinski, Mark A ; Ozguroglu, Mustafa ; Villegas, Augusto...
Clinical Lung Cancer.  , 2021
Link: https://doi.org/10.1016/..
 
?
10

Three-Year Overall Survival with Durvalumab after Chemoradi..:

Gray, Jhanelle ; Villegas, Augusto ; Daniel, Davey...
Journal Of Thoracic Oncology.  , 2020
Link: https://doi.org/10.1016/..
 
?
11

Brief report: Three-year overall survival with durvalumab a..:

Gray, Jhanelle E ; Villegas, Augusto ; Daniel, Davey...
Gray , J E , Villegas , A , Daniel , D , Vicente , D , Murakami , S , Hui , R , Kurata , T , Chiappori , A , Lee , K H , Cho , B C , Planchard , D , Paz-Ares , L , Faivre-Finn , C , Vansteenkiste , J F , Spigel , D R , Wadsworth , C , Taboada , M , Dennis , P A , Özgüroğlu , M & Antonia , S J 2020 , ' Brief report: Three-year overall survival with durvalumab after chemoradiotherapy in Stage III NSCLC - Update from PACIFIC ' , Journal of Thoracic Oncology , vol. 15 , no. 2 , pp. 288-293 . https://doi.org/10.1016/j.jtho.2019.10.002.  , 2020
Link: https://research.manches..
 
?
12

Impact of prior chemoradiotherapy-related variables on outc..:

Faivre-Finn, Corinne ; Spigel, David R ; Senan, Suresh...
http://hdl.handle.net/10668/16748.  , 2020
Link: http://hdl.handle.net/10..
 
?
13

Impact of prior chemoradiotherapy-related variables on outc..:

Faivre-finn, Corinne ; Spigel, David R ; Senan, Suresh...
Faivre-finn , C , Spigel , D R , Senan , S , Langer , C , Perez , B A , Özgüroğlu , M , Daniel , D , Villegas , A , Vicente , D , Hui , R , Murakami , S , Paz-ares , L , Broadhurst , H , Wadsworth , C , Dennis , P A & Antonia , S J 2020 , ' Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC) ' , Lung Cancer . https://doi.org/10.1016/j.lungcan.2020.11.024.  , 2020
Link: https://research.manches..
 
?
14

Three-Year Overall Survival with Durvalumab after Chemoradi..:

Gray, Jhanelle E ; Villegas, Augusto ; Daniel, Davey...
http://hdl.handle.net/10668/14900.  , 2019
Link: http://hdl.handle.net/10..
 
?
15

Overall survival with durvalumab after chemoradiotherapy in..:

Antonia, Scott J ; Villegas, Augusto ; Daniel, Davey...
Antonia , S J , Villegas , A , Daniel , D , Vicente , D , Murakami , S , Hui , R , Kurata , T , Chiappori , A , Lee , K H , De Wit , M , Cho , B C , Bourhaba , M , Quantin , X , Tokito , T , Mekhail , T , Planchard , D , Kim , Y , Karapetis , C S , Hiret , S , Ostoros , G , Kubota , K , Gray , J E , Paz-ares , L , De Castro Carpeño , J , Faivre-finn , C , Reck , M , Vansteenkiste , J , Spigel , D R , Wadsworth , C , Melillo , G , Taboada , M , Dennis , P A & Özgüroğlu , M 2018 , ' Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC : Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC ' , New England Journal Of Medicine , vol. 379 , no. 24 , pp. 2342-2350 . https://doi.org/10.1056/NEJMoa1809697.  , 2018
Link: https://research.manches..
 
1-15